Merck KGaA (Germany) and Danaher Corporation (US) are Leading Players in the Pharmaceutical Membrane Filtration Market
The global pharmaceutical membrane filtration market is projected to reach USD 19.6 billion by 2029 from USD 10.6 billion in 2024, at a CAGR of 13.1% during the forecast period of 2024 to 2029. Growth in the pharmaceutical membrane filtration market can be attributed to factors such as increasing R&D spending in pharmaceutical & biotechnology industries, increasing adoption of single-use technologies, high purity requirements among end users, and strict regulatory requirements. On the other hand, membrane fouling issues along with the high capital investment required to set up new production facilities are expected to hinder market growth.
The global pharmaceutical membrane filtration market is consolidated, with Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M Company (US), Thermo Fisher Scientific, Inc. (US) accounting for the majority of the market share globally.
To know about the assumptions considered for the study download the pdf brochure
Merck KGaA is one of the leading player in the pharmaceutical membrane filtration market. The company has strengthened its global position by offering a wide range of pharmaceutical membrane filtration products for end users operatig in the pharmaceutical membrane filtration market. With a strong geographic reach, a broad portfolio of pharmaceutical membrane filtration products, and continuous expansion in developed as well as developing regions, the company is expected to grow at a high rate in the pharmaceutical filtration market during the forecast period.
Danaher Corporation became one of the most prominent players in the pharmaceutical membrane filtration market after its acquisition of Pall Corporation. The company operates as one of the top players in the pharmaceutical filtration market with its strong portfolio of membrane filters, systems & other filtration solutions. Danaher Corporation focuses on growth strategies such as agreements, acquisitions, and expansions to strengthen its global position in the market. For instance, in the last three years, Danaher has engaged in acquisitions and agreements with Austar LifeSciences (China), Servier Laboratories (France), New Jersey Innovation Institute (US), General Electric-Life Sciences (US), and Sartorius AG (Germany).
Sartorius AG is among the top 5 players in the pharmaceutical membrane filtration market with a wide range of pharmaceutical membrane filtration products addressing the needs of CROs, CDMOs, and pharma & biopharma companies. High investment in R&D has enabled the company to launch products such as Sartolab RF|BT Vacuum Filtration Units for laboratory filtration applications. Further, the company has actively engaged in strategic expansions owing to the increasing demand for its products.
Related Reports:
Pharmaceutical Membrane Filtration Market by Product (Filters (PES, PVDF, Nylon), Systems (Single use)), Technique (Microfiltration, Ultrafiltration), Application (API, Vaccines), Type (Sterile, Non Sterile), Scale of Operation - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
